Brief: Zelira Therapeutics Says Zenivol Receives Formal Approval From German Regulatory
13/07/2022 02:24
July 13 (Reuters) - Zelira Therapeutics Ltd ZLD.AX :
* ZELIRA THERAPEUTICS - ZENIVOL RECEIVES FORMAL APPROVAL
FROM
GERMAN REGULATORY AUTHORITY BFARM, FOR COMMERCIALISATION BY
ADJUPHARM GMBH
Source text for Eikon: ID:nASX3RgkpJ
Further company coverage: ZLD.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zelira Therapeutics
See all newsBrief: Zelira Therapeutics Announces $33 MLN Fundraising Into Zeliras HOPE 1 SPV
Australia's Zelira Therapeutics surges on $33 million funding for drug trial
Australia's Zelira Therapeutics climbs to over 7-month high on securing patents
Brief: Zelira Therapeutics Receives USD$1.4 Million Unsecured Loan Funds From Chairman
Brief: Zelira Therapeutics Ltd Says Zld Secures Us$1.4M Unsecured Chairman Loan Facility